Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DiverDrugs is a biotechnology company based in Barcelona, Spain, specializing in the design and synthesis of combinatorial libraries of small molecules and peptides. The company operates as a contract research organization (CRO) and a drug discovery firm, leveraging its expertise in solid-phase synthesis and high-throughput screening to identify novel therapeutic candidates. DiverDrugs focuses on developing ligands for G protein-coupled receptors (GPCRs), with specific interests in melanocortin, opioid, and tachykinin receptors. Their services support pharmaceutical and biotech partners in the early stages of drug discovery, from lead identification to optimization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DiverDrugs.